Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
14.1M
-
Shares change
-
+281K
-
Total reported value, excl. options
-
$257M
-
Value change
-
+$1.94M
-
Put/Call ratio
-
1.28
-
Number of buys
-
50
-
Number of sells
-
-41
-
Price
-
$18.27
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q3 2014
106 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q3 2014.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.1M shares
of 386M outstanding shares and own 3.65% of the company stock.
Largest 10 shareholders include HEARTLAND ADVISORS INC (1.2M shares), CARDINAL CAPITAL MANAGEMENT LLC /CT (954K shares), ACK Asset Management LLC (750K shares), Lyon Street Capital, LLC (740K shares), WHITEBOX ADVISORS LLC (707K shares), THOMSON HORSTMANN & BRYANT INC (671K shares), Park West Asset Management LLC (601K shares), BLAIR WILLIAM & CO/IL (595K shares), CHARTWELL INVESTMENT PARTNERS, INC. (557K shares), and Cortina Asset Management, LLC (549K shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.